Archives

by in
Entry Author Date Location
NeuWave Grabs $25M to Amplify Overseas Sales of Tumor-Zapping Tech 05/28/15 Wisconsin
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
West Coast Biotech Roundup: Kythera, Amgen, Otonomy, Versant & More 04/30/15 San Diego
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
In Venture Reinvention, Versant Sees Gains Amid Biotech Boom Times 04/29/15 National
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
Rechristened Laguna Pharmaceuticals Raises $30M, Moves To San Diego 02/17/15 San Diego
Intrigue and Outdated Rules Complicate Big Biotech Patent Fight 12/16/14 National
West Coast Biotech Roundup: Versant, BayBio/CHI Merger, von Emster 12/11/14 San Francisco
West Coast Biotech Roundup: Ebola, Immunotherapy, Avalon & More 09/26/14 San Francisco
From Autism to Diabetes to HIPAA, Rock Health Seeds 8 More Startups 08/18/14 San Francisco
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
West Coast Biotech Roundup: Scripps, Trounson, Versant, Gilead, & More 07/10/14 San Francisco
Oh Canada! Versant’s Strategic Shifts Lead to $300M Fund 07/08/14 San Francisco
Langer, Led Zeppelin, and Hookups: Three Days Behind the BIO Scenes 06/27/14 San Diego
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
Tapping UCSF Invention, Roche and Versant Dive Into Myelin Repair 06/23/14 San Francisco
After Time For Family, Reflection, VC Samuels Emerges At Venrock 05/19/14 San Francisco
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia 04/15/14 Boston
San Diego’s RuiYi Raises $15M for Pipeline of Biologic Therapeutics 03/28/14 San Diego
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Inception 4 Lands $10,000,000 Series A Funding Round 12/13/13 San Diego
Veracyte, Thyroid Cancer Diagnostic Player, Pulls Off IPO 10/30/13 San Francisco
Immune Design Garners $49,000,000 Series C Financing 10/30/13 Seattle
Audentes, Loaded With $30M, Pursues Gene Therapy for Rare Diseases 07/26/13 San Francisco
Audentes Therapeutics Obtains $30,000,000 Series A Funding Round 07/19/13 San Francisco
Ceterix Comes Out With Tool to Repair, Not Remove, Knee Cartilage 07/16/13 San Francisco
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Page 1 of 7 next page »